EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

miR-500a-3p negatively regulates SOCS2 and participates in the proliferation, glycolysis, and apoptosis of HCC cells via the JAK2/STAT5 pathway

Shan Li, Wei Luo, Wei Liu

Journal of Applied Biomedicine · 2026

DOI: 10.32725/jab.2026.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Applied Biomedicine, 2026. Verfasst von Shan Li und 2 weiteren Autor:innen. Beteiligte Einrichtung: Affiliated Hospital of Hubei University of Science and Technology, Xiantao First People's Hospital, Department of Endocrinology, Xiantao City 433000,…. Hauptthemen laut MEDLINE: MicroRNAs, Janus Kinase 2, Suppressor of Cytokine Signaling Proteins, Apoptosis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: HCC is a prevalent malignant tumor globally with high mortality. MiR-500a-3p plays critical roles in tumorigenesis and tumor progression. METHODS: To evaluate miR-500a-3p's role in HCC, we first analyzed its expression and prognostic value via qRT-PCR and TCGA (Kaplan-Meier analysis). We then performed extensive in vitro functional studies after cell transfection (mimics, anti-miR, SOCS2 OE), measuring proliferation, migration, invasion, glycolytic parameters (glucose consumption, lactate, ECAR, ATP), and apoptosis. A target relationship with SOCS2 was predicted bioinformatically and confirmed by dual-luciferase assay. Using the JAK2/STAT5 signaling pathway inhibitor Fedratinib, the activator Erythropoietin, and transfection with si-STAT5 and oe-STAT5, the molecular mechanism of miR-500a-3p in HCC was investigated. In vivo experiments established tumor-bearing mouse models to evaluate the effect of miR-500a-3p on tumor growth. RESULTS: miR-500a-3p was significantly upregulated in HCC tissues and cells, and was associated with poor patient prognosis. The overexpression of miR-500a-3p promotes the malignant progression of HCC cells. Mechanistically, miR-500a-3p directly targeted and negatively regulated SOCS2 expression. SOCS2 expression was suppressed in HCC, with its expression abrogating miR-500a-3p-mediated oncogenicity. miR-500a-3p activated the JAK2/STAT5 pathway by inhibiting SOCS2, thereby regulating the malignant biological behaviors of HCC cells. Both SOCS2 overexpression and JAK2 inhibitor treatment could reverse the activation of the JAK2/STAT5 axis and downstream effects induced by miR-500a-3p. MiR-500a-3p promoted tumor growth in tumor-bearing mice, accompanied by SOCS2 downregulation and JAK2/STAT5 pathway activation. CONCLUSION: This study reveals that miR-500a-3p promotes proliferation and glycolysis while inhibiting apoptosis of HCC cells by negatively regulating SOCS2 and activating the JAK2/STAT5 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsJanus Kinase 2Suppressor of Cytokine Signaling ProteinsApoptosisSTAT5 Transcription FactorGlycolysisCarcinoma, HepatocellularLiver NeoplasmsHumansCell ProliferationAnimalsSignal TransductionMiceCell Line, TumorGene Expression Regulation, NeoplasticMaleMice, NudeMice, Inbred BALB CFemaleCell Movement

Stichwörter der Autor:innen

ApoptosisGlycolysisHepatocellular carcinomaProliferationSOCS2miR-500a-3p

Substanzen

MicroRNAsJanus Kinase 2Suppressor of Cytokine Signaling ProteinsSOCS2 protein, humanSTAT5 Transcription FactorJAK2 protein, human

Autor:innen und Institutionen

  • Affiliated Hospital of Hubei University of Science and Technology, Xiantao First People's Hospital, Department of Endocrinology, Xiantao City 433000, Hubei Province, China.
  • Jianli People's Hospital Affiliated to China Three Gorges University, Department of Oncology, Rongcheng Town, Jianli City 433300, Hubei Province, China.
  • Affiliated Hospital of Hubei University of Science and Technology, Xiantao First People's Hospital, Department of Gastrointestinal Surgery, Xiantao City 433000, Hubei Province, China.

Zitieren

APA

Li, S., Luo, W., & Liu, W. (2026). miR-500a-3p negatively regulates SOCS2 and participates in the proliferation, glycolysis, and apoptosis of HCC cells via the JAK2/STAT5 pathway. Journal of Applied Biomedicine. https://doi.org/10.32725/jab.2026.002

Vancouver

Li S, Luo W, Liu W. miR-500a-3p negatively regulates SOCS2 and participates in the proliferation, glycolysis, and apoptosis of HCC cells via the JAK2/STAT5 pathway. Journal of Applied Biomedicine. 2026. doi:10.32725/jab.2026.002

BibTeX
@article{Li2026,
  author = {Li, Shan and Luo, Wei and Liu, Wei},
  title = {miR-500a-3p negatively regulates SOCS2 and participates in the proliferation, glycolysis, and apoptosis of HCC cells via the JAK2/STAT5 pathway},
  journal = {Journal of Applied Biomedicine},
  year = {2026},
  doi = {10.32725/jab.2026.002}
}
Kostenlos starten →